MabCure, Inc. Announces Positive Results for New Ovarian Cancer Diagnostic Blood Test
HASSELT, Belgium—-Biotechnology company MabCure, Inc. today announced that a confirmatory study demonstrated the companys proprietary monoclonal antibodies successfully identified ovarian cancer in blood and with no false positives or cross-reactions with benign ovarian tumors or healthy blood.
Read more on Business Wire via Yahoo Finance
iMedicor [...] http://bit.ly/9h706u
No comments:
Post a Comment